665 related articles for article (PubMed ID: 20217050)
1. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
Biala G; Staniak N; Budzynska B
Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):361-70. PubMed ID: 20217050
[TBL] [Abstract][Full Text] [Related]
2. Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Biala G; Budzynska B; Staniak N
Behav Brain Res; 2009 Sep; 202(2):260-5. PubMed ID: 19463710
[TBL] [Abstract][Full Text] [Related]
3. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
Biala G; Staniak N
Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
[TBL] [Abstract][Full Text] [Related]
4. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
Cunningham CS; McMahon LR
Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
[TBL] [Abstract][Full Text] [Related]
5. Effects of bupropion on the reinstatement of nicotine-induced conditioned place preference by drug priming in rats.
Budzyńska B; Biała G
Pharmacol Rep; 2011; 63(2):362-71. PubMed ID: 21602591
[TBL] [Abstract][Full Text] [Related]
6. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
[TBL] [Abstract][Full Text] [Related]
7. Brain nicotinic acetylcholine receptors are involved in stress-induced potentiation of nicotine reward in rats.
Javadi P; Rezayof A; Sardari M; Ghasemzadeh Z
J Psychopharmacol; 2017 Jul; 31(7):945-955. PubMed ID: 28541827
[TBL] [Abstract][Full Text] [Related]
8. Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists.
Biala G; Budzynska B
Eur J Pharmacol; 2006 May; 537(1-3):85-93. PubMed ID: 16616917
[TBL] [Abstract][Full Text] [Related]
9. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward.
Rezayof A; Zatali H; Haeri-Rohani A; Zarrindast MR
Behav Brain Res; 2006 Jan; 166(2):281-90. PubMed ID: 16191443
[TBL] [Abstract][Full Text] [Related]
10. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Ortiz NC; O'Neill HC; Marks MJ; Grady SR
Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
[TBL] [Abstract][Full Text] [Related]
11. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
[TBL] [Abstract][Full Text] [Related]
12. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
O'Connor EC; Parker D; Rollema H; Mead AN
Psychopharmacology (Berl); 2010 Feb; 208(3):365-76. PubMed ID: 19967529
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic acetylcholine receptors of the dorsal hippocampus and the basolateral amygdala are involved in ethanol-induced conditioned place preference.
Zarrindast MR; Meshkani J; Rezayof A; Beigzadeh R; Rostami P
Neuroscience; 2010 Jun; 168(2):505-13. PubMed ID: 20381593
[TBL] [Abstract][Full Text] [Related]
14. Blocking α4β2 and α7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice.
Feng B; Xing JH; Jia D; Liu SB; Guo HJ; Li XQ; He XS; Zhao MG
Behav Brain Res; 2011 Jun; 220(1):100-5. PubMed ID: 21277332
[TBL] [Abstract][Full Text] [Related]
15. Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids.
Cunningham CS; McMahon LR
Psychopharmacology (Berl); 2013 Jul; 228(2):321-33. PubMed ID: 23494230
[TBL] [Abstract][Full Text] [Related]
16. Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Biala G; Budzynska B
Pharmacol Biochem Behav; 2008 Mar; 89(1):116-25. PubMed ID: 18178244
[TBL] [Abstract][Full Text] [Related]
17. Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats.
Gawel K; Labuz K; Jenda M; Silberring J; Kotlinska JH
Behav Brain Res; 2014 Jul; 268():169-76. PubMed ID: 24755308
[TBL] [Abstract][Full Text] [Related]
18. Differences between nicotine and cocaine-induced conditioned place preferences.
Sershen H; Hashim A; Lajtha A
Brain Res Bull; 2010 Jan; 81(1):120-4. PubMed ID: 19665529
[TBL] [Abstract][Full Text] [Related]
19. Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference.
Zarrindast MR; Fattahi Z; Rostami P; Rezayof A
Pharmacol Biochem Behav; 2005 Sep; 82(1):1-10. PubMed ID: 16054206
[TBL] [Abstract][Full Text] [Related]
20. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
